Regulatory Story
Go to market news section View chart   Print
RNS
Huntsworth PLC  -  HNT   

Interim Results for the six months to 30 June 2017

Released 07:00 26-Jul-2017

RNS Number : 0805M
Huntsworth PLC
26 July 2017
 

               

 

 

Huntsworth

Interim results for the six months to 30 June 2017

 

Continuing recovery with strong organic growth

 

·     Headline profit before tax up by 58%

·     Interim dividend increased by 10% to 0.55p

·     Strong growth from Huntsworth Health

·     Grayling returns to profit

·     Acquisition of The Creative Engagement Group (TCEG) in July 2017

 

 

Huntsworth plc, the healthcare communications and public relations group, today announces its interim results for the six months to 30 June 2017.

Financial highlights

 

30 June

 2017

30 June

 2016

 

Revenue

£94.2m

£86.6m

+9%

Profit / (loss) before tax

£9.2m

£(8.9)m

 

Diluted profit / (loss) per share

1.6p

(2.7)p

 

 

 

 

 

Headline operating profit1

£11.0m

£7.3m 

+50%

Headline profit before tax1

£10.0m

£6.4m

+58%

Headline basic & diluted EPS1

2.4p

1.7p

+41%

 

 

 

 

Dividend per share

0.55p

0.50p

+10%

Net debt

£26.8m

£37.1m

 

 

 

Paul Taaffe, CEO of Huntsworth plc, commented:

"The Group grew very strongly through the first half of 2017 led by Huntsworth Health assisted by favourable movements in exchange rates. Grayling has responded well to last year's restructuring with a return to profit. Our momentum going into the second half remains strong, driven by continued growth at Huntsworth Health, the first time impact of the TCEG acquisition and improving trading at Grayling."

 

 Notes:

1.   Unless otherwise stated, results have been adjusted to exclude highlighted items. An explanation of how all adjusted measures have been calculated is included in Appendix 1.

 

 

Enquiries

Huntsworth

020 3861 3999

Paul Taaffe, Chief Executive Officer

 

Neil Jones, Chief Financial Officer             

 

 

 

Citigate Dewe Rogerson

020 7638 9571

Simon Rigby

 

Elizabeth Kittle

 

 

Chief Executive's Statement

 

Group overview

Revenues for the first half of 2017 were £94.2 million (2016: £86.6 million), an increase of 9% compared to the prior year, or 7% on a like-for-like2 basis. Profit before tax and highlighted items was £10.0 million (2016: £6.4 million), an increase of 58%.

The first half of the year has seen the Group perform strongly, driven by Huntsworth Health, which grew its revenue and profits by nearly 20% on a like-for-like basis, and assisted by a stronger US dollar. In addition, Grayling has returned to profit in the first half of the year, with three of its four operating units now making a positive contribution to the Group. Red has grown well in a flat market, although growth is expected to slow in H2 as client changes begin to impact, while Citigate Dewe Rogerson was slightly behind 2016 mainly due to the previously highlighted weaker trading conditions in Asia.

Our main focus for growth and investment remains Huntsworth Health. Healthcare is a growing sector as clients seek a more differentiated and increasingly digital offering for their medical and marketing communications. To further support this we added The Creative Engagement Group ('TCEG') to our portfolio of leading agencies in July 2017 for cash consideration of £24.7 million. TCEG consists of three agencies that provide experiential marketing, primarily to Healthcare clients, and its acquisition will further strengthen our ability to provide high quality digital creativity to clients, whilst allowing TCEG to benefit from access to the Group's existing Healthcare clients.

The Group's cash flow remained strong during the period, with a net operating inflow before highlighted items of £6.4 million (2016: £0.1 million) representing a cash conversion of 58%, ahead of our normal H1 average.  Net debt at 30 June 2017 was £26.8 million (2016: £37.1 million).

Notes:

2.          Like-for-like revenues are stated at constant exchange rates and are adjusted to include pre-acquisition revenues and exclude disposals/closures. A reconciliation of like-for-like measures to IFRS measures is included in Appendix 1.

Divisional overview

Huntsworth Health

First half-year 2017 revenues grew 33% or 20% on a like-for-like basis to £55.3 million, delivering an operating margin of 19.2% (H1 2016 19.4%).

Huntsworth Health continues to perform well, with strong double-digit revenue and operating profit growth. This growth continues to be driven by our largest agencies, with Evoke Health, our full service digital consumer agency, growing like-for-like revenues by 26.4%, and Apothecom, our medical communications and market access agency, growing like-for-like revenues by 15.3%. Together these two agencies now represent over 80% of divisional revenue. Profit margins across the division were in line with 2016 despite continued investment, most notably in a new multicultural agency within Evoke called Fabric together with market access at Apothecom. In terms of geographical spilt the division remains heavily weighted to the US, with nearly 90% of revenues generated there.

New business momentum remains good going into H2, although revenue growth will be slower than H1, which was exceptionally high. Consistent with our growth plan, we have won business from an expanded client base with wins across our healthcare verticals.

The addition of TCEG's experiential and internal communications skills to the portfolio brings significant revenues from new and existing Healthcare clients, and allows the divisional agencies the ability to offer an expanded range of services, which should allow TCEG to grow its US revenues from its current level of around one third of total revenues. 

Grayling

Grayling revenues fell 24%, or 13% on a like-for-like basis, to £21.0 million, resulting in a profit of £0.4m for the period (H1 2016: loss of £0.1m). This performance is in line with our expectations as we develop Grayling into a more focused business that operates profitable agencies.

At 30 June 2017, continental Europe, the UK operations (together representing circa 70% of divisional revenues) and the Middle East and Africa region are all now profitable. We have further restructured the US PR offering with the aim of returning that business to profitability by the start of 2018.

Performance has differed between regions in the first half of 2017. Continental Europe remains the strongest and most profitable part of the division but has had a mixed performance in H1 with good growth in Eastern Europe offset by a disappointing performance in Western Europe. Overall like-for-like revenues are 6% down on H1 2016.

Following a restructure in 2015/2016 and the elimination of incremental costs from consolidating the London property portfolio, the UK business made good progress, retaining a number of major clients, generating positive net new client wins and attracting high quality new talent.

After a very difficult 2016, the Middle East & Africa division has returned to profit. Following its exit from Turkey and Qatar due to extremely difficult trading and political conditions, the division is now focused on the UAE and Kenya, both of which have made strong progress during the period.

The US business consists of a federal lobbying business in Washington DC, which remains profitable, and a general PR business which continues to transition to a broader client portfolio.

Red

Red performed well in the first half of the year with revenues growing by 5% to £6.9 million. Operating profit for the half year grew by 16% to £1.4 million, with margins improving from 18.2% to 20.1%.  Following some movements in the client portfolio, growth is expected to be slower in H2.

Citigate Dewe Rogerson (CDR)

CDR's revenues grew by 2% due largely to the impact of positive exchange rates; on a like-for-like basis revenues fell 3%, to £10.9 million, delivering margins of 13.0% (H1 2016 15.1%).

The decrease was primarily driven by the Asia Pacific offices of CDR, with like-for-like revenues from Greater China down 14% and Singapore down 9%, reflecting a quieter transaction market in these regions.

Trading conditions were mixed in the UK, with a strong performance from financial PR with some notable project wins, offset by a weaker performance from corporate PR. Overall the UK agency saw a small fall in like-for-like revenues and margins, which resulted in an adjustment to staffing levels.

Continental Europe was broadly flat on H1 2016, with a strong performance in the Netherlands largely offset by a weaker performance in France.

Dividend

Given the strength of the Group's H1 performance and the outlook for the remainder of the year the interim dividend is being raised by 10% to 0.55p (H1 2016: 0.5p).

Group outlook

We expect to see a continued good performance across the Group in the second half of the year, again led by the Healthcare Division, along with the first time inclusion of TCEG.  We expect Grayling to continue to deliver improved profitability, whilst CDR should benefit from the cost savings implemented in the first half of the year.

 

Review of Financial Results

Summary of financial results for the six months ended 30 June 2017

 

 

2017

Like-for-like growth

2016

 

 

£m

%

£m

 

Revenue

 

 

 

 

Huntsworth Health

55.4

19.6%

41.5

 

Grayling

21.0

(13.3)%

27.8

 

CDR

10.9

(3.2)%

10.7

 

Red

6.9

5.2%

6.6

 

Total revenue

94.2

6.6%

86.6

 

 

2017

Margin

2016

Margin

 

£m

%

£m

%

Operating profit/(loss)

 

 

 

 

Huntsworth Health

10.7

19.2%

8.0

19.4%

Grayling

0.4

2.1%

(0.1)

(0.3)%

CDR

1.4

13.0%

1.6

15.1%

Red

1.4

20.1%

1.2

18.2%

Total operations

13.9

14.7%

10.7

12.4%

Central costs

(3.0)

 

(3.4)

 

Associates

0.1

 

-

 

Operating profit before highlighted items

11.0

11.5%

7.3

8.5%

Highlighted items (Note 3)

(0.9)

 

(15.2)

 

Reported operating profit/(loss)

10.1

 

(7.9)

 

 

 

 

 

 

Adjusted basic & diluted EPS

2.4p

 

1.7p

 

Reported basic & diluted EPS

1.6p

 

(2.7)p

 

 

 

 

Revenue and profit before highlighted items

 

Revenue in the six months to 30 June 2017 increased by £7.6 million to £94.2 million (H1 2016: £86.6 million).

 

On a like-for-like basis, revenues grew by 19.6% in Huntsworth Health and 5.2% in Red.  Revenues declined by 13.3% in Grayling and 3.3% in CDR.

 

Group operating margins rose from 8.5% to 11.5%, primarily reflecting strong growth from Huntsworth Health, which has higher margins, and a return to profitability in Grayling.

 

Highlighted items

 

Highlighted items in the first half of 2017 relate primarily to the amortisation of intangible assets (£0.4 million) and acquisition related costs (£0.4 million).  Highlighted items in H1 2016 included an impairment of £15.0 million in respect of Grayling goodwill.

 

After highlighted items, the statutory reported operating profit was £10.1 million (H1 2016: loss of £7.9 million).

 

Currency

 

The impact of changes in exchange rates against H1 2016 was to increase revenues by £7.9 million and increase operating profits by £2.5 million, which includes £1.3 million of incremental gains on hedging instruments.

 

Although the average sterling rate in H1 2017 was weaker than H1 2016, sterling actually strengthened between 31 December 2016 and 30 June 2017 resulting in a £3.6 million debit to Other Comprehensive Income and Expense arising from the retranslation of the Group’s overseas assets.

 

Tax

 

The total tax charge of £3.9 million comprises a tax charge of £2.2 million on underlying earnings and £1.7 million on highlighted items.  The pre-highlighted tax expense is based on the expected full year tax rate of 22% (year ended 31 December 2016: 18%). For the periods ended 30 June 2016 and 31 December 2016 the Group has reclassified the deferred tax expense on US intangible assets from profit before tax and highlighted items into highlighted items. This is on the basis that the deferred tax expense would only ever crystallise on a sale of the relevant businesses, which is not anticipated at the current time, and such a sale would be a highlighted item. 

 

Earnings per share

 

Profits attributable to ordinary shareholders before highlighted items were £7.8 million (H1 2016: £5.5 million). Adjusted basic and diluted earnings per share increased to 2.4p (H1 2016: 1.7p).

Profits attributable to ordinary shareholders after highlighted items were £5.3 million (H1 2016: loss £8.9 million), resulting in basic and diluted earnings per share of 1.6p (H1 2016: loss of 2.7p).

 

Dividends

Given the strength of the Group’s H1 performance and the outlook for the remainder of the year the interim dividend is being raised by 10% to 0.55p (H1 2016: 0.5 pence).  The record date for this dividend will be 29 September 2017 and it is payable on 6 November 2017. A scrip dividend alternative will be available.

 

Balance sheet and cash flow

Cash inflow from operations totalled £6.4 million (H1 2016: £0.1 million), before highlighted cash outflows of £1.3 million. Other principal cashflows during the period were net payments for interest, tax and non-current assets of £3.1 million (H1 2016: £5.2 million), offset by the proceeds on the sale of Whiteboard and Hudson Sandler of £2.4 million.

Net debt at 30 June 2017 was £26.8 million (30 June 2016: £37.1 million; 31 December 2016: £31.6 million) which is within the Group’s available facilities. Financial covenants based on the Group’s facility agreements continue to be comfortably met.

On 3 July 2017, after the period end, the Group exercised its accordion option to extend its available facilities to £80 million, which remain committed until 31 May 2019.

 

Key risks and uncertainties

The Directors monitor the risks that the Group is exposed to and the risk management processes and internal controls in place to mitigate these risks. Our risk management approach is led by the Risk Committee and is designed to identify risks to the Group using both a bottom-up and top-down approach. 

The Directors have considered whether the nature or level of risk that the Group is exposed to has changed significantly in the first half of 2017 and have concluded that whilst uncertainties remain in the macroeconomic environment, particularly around the UK’s exit from the European Union, the risk profile is largely unchanged.  The Directors continue to review risk levels and will act to mitigate any increased risks accordingly.

As described more fully on pages 26 to 29 of the 2016 Annual Report and Accounts, the Group's key risks and uncertainties are identified as:

The Group has a number of ongoing processes to identify, evaluate and manage the key financial, operating and compliance risks faced by the Group and for determining the appropriate course of action to manage and mitigate those risks.  The Board delegates the monitoring of these internal control and risk management processes to the Audit Committee, and in turn to the Risk Committee.  Further details of the risk management processes undertaken are included on page 36 of the 2016 Annual Report and Accounts.

 

Forward looking statements

The interim management report contains certain forward looking statements in respect of Huntsworth plc and the operation of its subsidiaries. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements and forecasts. Nothing in this announcement should be construed as a profit forecast.

Condensed Consolidated Income Statement

for the six months ended 30 June 2017

 

 

 

 

Notes

Unaudited

6 months ended 30 June

2017

£000

Unaudited

6 months ended 30 June

2016

£000

Audited

Year ended

31 December 2016

 £000

 

Turnover

 

111,949

104,818

216,145

 

 

 

 

 

 

 

Revenue

2

94,200

86,556

180,137

 

Operating expenses

 

(84,178)

(94,436)

(194,723)

 

Share of profit from associate

 

99

-

57

 

Operating profit/(loss)

2

10,121

(7,880)

(14,529)

 

Finance income

4

3

5

9

 

Finance costs

4

(941)

(978)

(1,982)

 

Profit/(loss) before tax

 

9,183

(8,853)

(16,502)

 

 

 

 

 

 

 

Comprising:

 

 

 

 

 

Profit before tax and highlighted items

3

10,039

6,354

16,005     

 

Highlighted items

3

(856)

(15,207)

(32,507)

 

 

 

9,183

(8,853)

(16,502)

 

 

 

 

 

 

 

Taxation expense

5

(3,882)

(26)

(1,759)

 

Profit/(loss) for the period attributable to Parent Company's equity shareholders

 

5,301

(8,879)

(18,261)

 

 

Profit/(loss) per share

 

 

 

 

Basic - pence

7

1.6

(2.7)

(5.6)

Diluted - pence

7

1.6

(2.7)

(5.6)

 

 

Condensed Consolidated Statement of Comprehensive Income

for the six months ended 30 June 2017

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Profit/(loss) for the period

5,301

(8,879)

(18,261)

 

 

 

 

Other comprehensive income and expense

 

 

 

Items that may be reclassified subsequently to the Income Statement

 

 

 

Currency translation differences

(3,607)

10,786

20,095

Tax credit on currency translation differences

53

386

-

Amounts recognised in the Income Statement on interest rate swaps

128

96

(664)

Movement in valuation of interest rate swaps

41

(754)

231

Tax (expense)/credit on interest rate swaps

(32)

132

82

Total items that may be reclassified subsequently to profit or loss

(3,417)

10,646

19,744

Other comprehensive income and expense for the period

(3,417)

10,646

19,744

Total comprehensive income and expense for the period attributable to Parent Company's equity shareholders

1,884

1,767

1,483

 

 

 

 

         

 

Condensed Consolidated Balance Sheet

as at 30 June 2017

 

 

Notes

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Non-current assets

 

 

 

 

Intangible assets

8

155,962

172,506

159,797

Property, plant and equipment

 

10,470

9,950

11,832

Investment in associate

9

281

-

182

Other receivables

 

717

170

188

Deferred tax assets

 

1,462

2,377

926

 

 

168,892

185,003

172,925

Current assets

 

 

 

 

Work in progress

 

7,360

5,021

5,396

Trade and other receivables

 

62,764

54,671

56,087

Current tax receivable

 

526

574

1,504

Derivative financial assets

10

495

-

-

Cash and short-term deposits

13

36,656

10,544

14,978

Assets of disposal group classified as held for sale

 

-

-

3,319

 

 

107,801

70,810

81,284

Current liabilities

 

 

 

 

Obligations under finance leases

 

(2)

(3)

(2)

Bank overdraft

 

(110)

-

(495)

Trade and other payables

 

(55,285)

(47,523)

(47,920)

Derivative financial liabilities

10

(232)

(581)

(154)

Current tax payable

 

(1,542)

(1,044)

(756)

Provisions

12

(521)

(1,322)

(1,979)

 

 

(57,692)

(50,473)

(51,306)

Non-current liabilities

 

 

 

 

Bank loans

11

(63,519)

(46,280)

(45,412)

Obligations under finance leases

 

(3)

(26)

(4)

Trade and other payables

 

(2,917)

(1,814)

(2,892)

Derivative financial liabilities

10

(124)

(750)

(525)

Deferred tax liabilities

 

(199)

(199)

(202)

Provisions

12

(1,292)

(2,147)

(1,553)

 

 

(68,054)

(51,216)

(50,588)

Net assets

 

150,947

154,124

152,315

Equity

 

 

 

 

Called up share capital

 

107,188

107,185

107,188

Share premium account

 

62,926

62,801

62,926

Merger reserve

 

29,468

29,468

29,468

Foreign currency translation reserve

 

40,397

34,695

44,004

Hedging reserve

 

(356)

(750)

(525)

Treasury shares

 

(1,166)

(1,166)

(1,166)

Investment in own shares held in the Employee Benefit Trusts

 

(1,764)

(1,867)

(1,764)

Retained earnings

 

(85,746)

(76,242)

(87,816)

Equity attributable to equity holders of the parent

 

150,947

154,124

152,315

Condensed Consolidated Cash Flow Statement

for the six months ended 30 June 2017

 

 

Notes

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Cash inflow/(outflow) from operating activities

 

 

 

 

Cash inflow/(outflow) from operations

13(a)

5,106

(1,342)

12,640

Interest paid

 

(694)

(795)

(1,629)

Interest received

 

3

4

6

Net tax paid

 

(1,352)

(505)

(2,107)

Net cash inflow/(outflow) from operating activities

 

3,063

(2,638)

8,910

 

 

 

 

 

Cash inflow/(outflow) from investing activities

 

 

 

 

Proceeds from sale of businesses, net of cash disposed

 

2,375

-

462

Acquisition of intangible assets

 

-

(488)

(488)

Cost of internally developed intangible assets

 

(180)

(505)

(933)

Purchases of property, plant and equipment

 

(887)

(2,930)

(5,053)

Proceeds from sale of property, plant and equipment

 

-

7

27

Net cash inflow/(outflow) from investing activities

 

1,308

(3,916)

(5,985)

 

 

 

 

 

Cash inflow/(outflow) from financing activities

 

 

 

 

Proceeds from sale of own shares to settle share options

 

-

251

251

Repayment of finance lease liabilities

 

(1)

(2)

(24)

Net drawdown of borrowings

 

17,975

6,975

5,975

Dividends paid to equity holders of the parent

 

-

-

(5,562)

Net cash inflow from financing activities

 

17,974

7,224

640

Increase in cash and cash equivalents

 

22,345

670

3,565

 

 

 

 

 

Movements in cash and cash equivalents

 

 

 

 

Increase in cash and cash equivalents

 

22,345

670

3,565

Effects of exchange rate fluctuations on cash held

 

(282)

956

2,000

Cash and cash equivalents at 1 January

 

14,483

8,918

8,918

Cash and cash equivalents at end of period

13(c)

36,546

10,544

14,483

 

 

 

Condensed Consolidated Statement of Changes in Equity

for the six months ended 30 June 2017

 

 

 

 

Called

 

 

Foreign

 

 

 

 

 

 

up

Share

 

currency

 

 

Investment

 

 

 

share

premium

Merger

translation

Hedging

Treasury

in own

Retained

Total

 

capital

account

reserve

reserve

reserve

shares

shares

earnings

Equity

 

£000

£000

£000

£000

£000

£000

£000

£000

£000

At 1 January 2016 (audited)

107,170

62,811

30,369

23,909

(92)

(1,166)

(4,095)

(63,604)

155,302

Loss for the period

-

-

-

-

-

-

-

(8,879)

(8,879)

Other comprehensive income/(expense)

-

-

-

10,786

(658)

-

-

518

10,646

Total comprehensive income/(expense)

-

-

-

10,786

(658)

-

-

(8,361)

1,767

Settlement of deferred consideration

15

-

593

-

-

-

-

-

608

Settlement of share options

-

-

-

-

-

-

2,228

(1,977)

251

Share issue costs

-

(10)

-

-

-

-

-

-

(10)

Charge for share-based payments

-

-

-

-

-

-

-

269

269

Tax on share-based payments

-

-

-

-

-

-

-

8

8

Equity dividends

-

-

-

-

-

-

-

(4,071)

(4,071)

Transfer

-

-

(1,494)

-

-

-

-

1,494

-

At 30 June 2016 (unaudited)

107,185

62,801

29,468

34,695

(750)

(1,166)

(1,867)

(76,242)

154,124

Loss for the period

-

-

-

-

-

-

-

(9,382)

(9,382)

Other comprehensive
income/(expense)

-

-

-

9,309

225

-

-

(436)

9,098

Total comprehensive income/(expense)

-

-

-

9,309

225

-

-

(9,818)

(284)

Settlement of share options

-

-

-

-

-

-

103

(103)

-

Share issue costs

-

(11)

-

-

-

-

-

-

(11)

Credit for share-based payments

-

-

-

-

-

-

-

(35)

(35)

Credit for unclaimed dividends

-

-

-

-

-

-

-

11

11

Tax on share-based payments

-

-

-

-

-

-

-

2

2

Scrip dividends

3

136

-

-

-

-

-

-

139

Equity dividends

-

-

-

-

-

-

-

(1,631)

(1,631)

At 31 December 2016 (audited)

107,188

62,926

29,468

44,004

(525)

(1,166)

(1,764)

(87,816)

152,315

Profit for the period

-

-

-

-

-

-

-

5,301

5,301

Other comprehensive (expense)/income

-

-

-

(3,607)

169

-

-

21

(3,417)

Total comprehensive (expense)/income

-

-

-

(3,607)

169

-

-

5,322

1,884

Charge for share-based payments

-

-

-

-

-

-

-

655

655

Tax on share-based payments

-

-

-

-

-

-

-

171

171

Equity dividends

-

-

-

-

-

-

-

(4,078)

(4,078)

At 30 June 2017 (unaudited)

107,188

62,926

29,468

40,397

(356)

(1,166)

(1,764)

(85,746)

150,947

 

 

Notes to the Financial Statements

 

1. Basis of preparation

The condensed consolidated unaudited interim financial statements for the six months ended 30 June 2017 have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, IAS 34 "Interim Financial Reporting" and the Group's accounting policies.

The Group's accounting policies are in accordance with International Financial Reporting Standards as adopted by the European Union and are set out in the Group's Annual Report and Accounts 2016 on pages 68 - 73, except as noted below. These are consistent with the accounting policies which the Group expects to adopt in its 2017 Annual Report. The Group has not early adopted any Standard, Interpretation or Amendment that has been issued but is not yet effective.

The information relating to the six months ended 30 June 2017 and 30 June 2016 is unaudited and does not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006. The information has however been reviewed by the auditors and their report to the Board of Huntsworth plc is set out on page 27 of this document. The comparative figures for the year ended 31 December 2016 have been extracted from the Group's Annual Report and Accounts 2016, on which the auditors gave an unmodified opinion and did not include a statement under section 498 (2) or (3) of the Companies Act 2006. The Group Annual Report and Accounts for the year ended 31 December 2016 have been filed with the Registrar of Companies.

 

Changes in accounting policies

A number of new and amended IFRS's have been adopted and none had any significant impact on the Group's financial statements. Other than IFRS 15 and IFRS 16, the adoption of the standards, amendments and interpretations issued but not effective is not expected to have a material impact on the Group's financial statements. The Directors are in the process of evaluating the impact of IFRS 15 and IFRS 16.

 

Going concern

After reviewing the Group's performance, future forecasted performance and cash flows, ability to draw down on its facilities and the covenant requirements of those facilities, and after considering the key risks and uncertainties set out on page 9, the Directors consider that the Group has sufficient resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Group's financial statements.

 

Reclassification of prior period information

For the periods ended 30 June 2016 and 31 December 2016 the Group has reclassified the deferred tax expense on US intangible assets from profit before tax and highlighted items into highlighted items. This is on the basis that the deferred tax expense would only ever crystallise on a sale of the relevant businesses, which is not anticipated at the current time, and such a sale would be a highlighted item.  

 

Estimates

The preparation of interim financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates. In preparing these condensed interim financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the consolidated financial statements for the year ended 31 December 2016.

 

2. Segmental analysis

 

The following is an analysis of the Group's revenue and operating profit before highlighted items by reportable segment.

 

The Group's business activities are split into four operating divisions: Citigate Dewe Rogerson (CDR), Grayling, Red and Huntsworth Health. These divisions are the basis on which information is reported to the Group's Chief Operating Decision Maker, which has been determined to be the Group Board. The segment result is the measure used for the purposes of performance assessment and represents profit earned by each segment, but before highlighted operating expenses, net finance costs and taxation.

 

 

 

CDR

Grayling

Red

Huntsworth Health

Total

6 months to 30 June 2017

£000

£000

£000

£000

£000

Segment revenue

10,890

21,028

6,938

55,344

94,200

Segment operating profit before highlighted items

1,417

442

1,391

10,631

13,881

 

 

CDR

Grayling

Red

Huntsworth Health

Total

6 months to 30 June 2016

£000

£000

£000

£000

£000

Segment revenue

10,655

27,817

6,598

41,486

86,556

Segment operating profit/(loss) before highlighted items

1,606

(85)

1,203

8,046

10,770

 

 

CDR

Grayling

Red

Huntsworth Health

Total

Year ended 31 December 2016

£000

£000

£000

£000

£000

Segment revenue

22,087

53,862

13,349

90,839

180,137

Segment operating profit/(loss) before highlighted items

3,584

(750)

2,710

18,299

23,843

 

Highlighted items are not presented to the Board on a segmental basis.

 

A reconciliation of segment operating profit before highlighted items to profit/(loss) before tax is provided below:

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Segment operating profit before highlighted items

13,881

10,770

23,843

Unallocated costs

(3,003)

(3,443)

(5,922)

Share of profit from associate

99

-

57

Operating profit before highlighted items

10,977

7,327

17,978

Highlighted items

(856)

(15,207)

(32,507)

Operating profit/(loss)

10,121

(7,880)

(14,529)

Net finance costs

(938)

(973)

(1,973)

Profit/(loss) before tax

9,183

(8,853)

(16,502)

 

3. Highlighted items

 

Notes

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Profit/(loss) before tax

 

9,183

(8,853)

(16,502)

Adjustments charged/(credited) to operating expenses:

 

 

 

 

Amortisation of intangible assets

8

395

439

840

Goodwill impairment

8

-

15,034

30,499

Impairment of software development costs

8

-

-

239

Restructuring costs

 

-

443

1,608

Remeasurement of contingent consideration receivable

 

102

-

-

Acquisition and transaction related charge/(credit)

 

359

(709)

(679)

Total adjustments charged to operating expenses

 

856

15,207

32,507

Adjusted profit before tax

 

10,039

6,354

16,005

 

 

Notes

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Charged to profit before tax

 

856

15,207

32,507

Taxation expense/(credit) on highlighted items

5

1,673

(873)

(1,132)

Charged to profit for the year

 

2,529

14,334

31,375

 

The Group presents highlighted items charged to profit before tax by making adjustments for costs and credits which management believe to be significant by virtue of their size, nature or incidence or which have a distortive effect on current year earnings. The Group uses these adjusted measures to evaluate performance and as a method to provide shareholders with clear and consistent reporting.

 

Amortisation of intangible assets

Intangible assets are amortised systematically over their estimated useful lives, which vary from 2 to 20 years depending on the nature of the asset. The amortisation charge in respect of intangible assets is excluded from adjusted results as they relate to historic business combinations rather than normal ongoing operations. 

 

Goodwill impairment

Impairments totalling £30.5 million were recognised relating to goodwill in the Grayling CGU in 2016. Impairment charges were individually disclosed and excluded from adjusted results as they do not relate to underlying trading.

 

Impairment of software development costs

The 2016 impairment related to significant adverse changes in the extent to which internally developed software was expected to be used. The charge was excluded from adjusted results as it did not relate to underlying trading.

 

Restructuring costs

Restructuring costs comprised cost-saving and right-sizing initiatives including severance payments, compensation for loss of office and other contract termination costs. Property costs relating to onerous contract provisions raised for property leases because of restructuring initiatives were included. These costs, which were part of the new management teams strategic refocus of the business, were excluded from adjusted results as they do not relate to underlying trading. These costs have not recurred as the restructuring was completed in 2016. 

 

Remeasurement of contingent consideration receivable

Effective 1 January 2017 the Whiteboard Advisors business was sold for initial consideration of $2.5million and a deferred element based on future performance. The loss of £0.1million relates to remeasuring the receivable to the period end exchange rate.  

 

Acquisition and transaction related charge/(credit)

Transaction costs are costs incurred in relation to business acquisitions and disposals. These costs are excluded from adjusted results as they are one-off in nature. The credits relate to the subsequent re-measurement of the fair value of deferred contingent consideration. These credits were excluded from adjusted results as they relate to historic business combinations rather than ongoing operations.

 

Taxation

The tax related to highlighted items is the tax effect of the items above.

 

4. Finance costs and income

 

Unaudited

6 months ended

30 June 2017

£000

Unaudited

6 months ended

30 June 2016

£000

Audited

Year ended

31

December 2016

 £000

Bank interest payable

935

958

1,955

Finance lease interest

-

1

-

Imputed interest on long term payables and provisions

19

Finance costs

941

978

1,982

Bank interest receivable

(1)

(1)

(2)

Other interest receivable

(2)

(4)

(7)

Finance income

(3)

(5)

(9)

Net finance costs

938

973

1,973

 

 

5. Tax

The tax expense for the six months ended 30 June 2017 has been based on an estimated effective tax rate on profit before tax and highlighted items for the full year of 22.0% (year ended 31 December 2016): 18.1%).  The tax expense is analysed as follows:

 

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

£000

Total:

 

 

 

Current tax

3,099

640

1,113

Deferred tax

783

(614)

646

Total tax expense

3,882

26

1,759

 

Comprising:

 

 

 

 

 

Income tax expense on profit before tax and highlighted items

 

2,209

899

2,891

 

Income tax expense/(credit) on highlighted items

 

1,673

 (873)

             (1,132)

 

 

 

3,882

26

                 1,759

 

 

The Finance Act 2016 was substantively enacted on 6 September 2016 and includes legislation to reduce the main rate of UK corporation tax to 19% from 1 April 2017 and 17% from 1 April 2020. The impact of this change is reflected in the numbers presented.

 

For the periods ended 30 June 2016 and 31 December 2016 the Group has reclassified the deferred tax expense on US intangible assets from profit before tax and highlighted items into highlighted items. This is on the basis that the deferred tax expense would only ever crystallise on a sale of the relevant businesses, which is not anticipated at the current time, and such a sale would be a highlighted item.  

 

6. Dividends

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Equity dividends on ordinary shares

 

 

 

Final dividend for the year ended 2015 - 1.25 pence

-

4,071

4,071

Interim dividend for the year ended 2016 - 0.5 pence

-

-

1,631

Final dividend for the year ended 2016 - 1.25 pence

4,078

-

-

 Total dividend expense

4,078

4,071

5,702

 

The final dividend for the year ended 31 December 2016 of 1.25 pence per share was approved by shareholders at the Annual General Meeting on 25 May 2017 and was paid on 6 July 2017. This dividend is included in trade and other payables at 30 June 2017.

 

The 2017 interim dividend of 0.55 pence per share was approved by the Board on 25 July 2017. The dividend will be paid on 6 November 2017 to those shareholders on the register on 29 September 2017.

 

7. Earnings per share

 

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

 

Basic earnings/(loss) per share - pence

1.6

(2.7)

(5.6)

 

Diluted earnings/(loss) per share - pence

1.6

(2.7)

(5.6)

 

Adjusted basic earnings per share - pence

2.4

1.7

4.0

 

Adjusted diluted earnings per share - pence

2.4

1.7

4.0

 

 

 

The data used in the calculation of the earnings per share numbers is summarised in the table below:

 

 

 

 

 

 

Unaudited 6 months ended 30 June 2017

Unaudited 6 months ended 30 June 2016

 Audited Year ended 31 December 2016

 

Earnings/(Loss)

£000

Weighted average number of shares

000's

Earnings/(Loss)

£000

Weighted average number of shares

000's

Earnings/(Loss)

£000

Weighted average number of shares

000's

Basic

5,301

326,248

(8,879)

324,446

(18,261)

325,245

Diluted

5,301

332,770

(8,879)

324,4461

(18,261)

325,2451

Adjusted basic

7,830

326,248

5,455

324,446

13,114

325,245

Adjusted diluted

7,830

332,770

5,455

325,574

13,114

329,488

               

1 As the basic EPS results in a loss per share, the diluted EPS is calculated using the undiluted weighted average number of shares.

 

The basic earnings per share calculation is based on the profit for the period attributable to parent company shareholders divided by the weighted average number of ordinary shares outstanding during the period.

Diluted earnings per share is calculated based on the profit for the period attributable to parent company shareholders divided by the weighted average number of ordinary shares outstanding during the period adjusted for the potentially dilutive impact of employee share option schemes and shares to be issued as part of contingent consideration on acquisition of subsidiaries. 

Adjusted earnings per share is calculated in order to provide information to shareholders about continuing trading performance and is based on the profit attributable to parent company shareholders excluding highlighted items together with related tax effects as set out below:

 

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Earnings/(loss):

 

 

 

Profit/(loss) for the period attributable to the Parent Company's shareholders

5,301

(8,879)

(18,261)

Highlighted items (net of tax) attributable to the Parent Company's shareholders

2,529

14,334

31,375

Adjusted earnings

7,830

5,455

13,114

 

 

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

 

Number of shares:

 

 

 

 

Weighted average number of ordinary shares - basic and adjusted basic

326,248

324,446

325,245

 

Effect of share options in issue

6,522

1,128

4,243

 

Weighted average number of ordinary shares - diluted and adjusted diluted

332,770

325,574

329,488

         

 

8. Intangible assets

 

Brands

Customer relationships

Goodwill

Intellectual property

Software development costs

Total

 

£000

£000

£000

£000

£000

£000

Cost

 

 

 

 

 

 

At 1 January 2017

27,875

35,100

336,775

1,754

4,713

406,217

Capitalised development costs

-

-

-

-

125

125

Foreign exchange movement

(399)

(1,049)

(5,340)

57

(82)

(6,813)

At 30 June 2017

27,476

34,051

331,435

1,811

4,756

399,529

Amortisation and impairment charges

 

 

 

 

 

 

At 1 January 2017

24,010

34,769

183,322

1,754

2,565

246,420

Charge for the period

249

146

-

-

142

537

Foreign exchange movement

(391)

(1,035)

(2,006)

57

(15)

(3,390)

At 30 June 2017

23,868

33,880

181,316

1,811

2,692

243,567

Net book value at 30 June 2017

3,608

171

150,119

-

2,064

155,962

Net book value at 31 December 2016

3,865

331

153,453

-

2,148

159,797

Net book value at 30 June 2016

4,077

445

165,864

5

2,115

172,506

 

There are no indicators of impairment for any of the CGUs at 30 June 2017.

 

9. Investment in associate

The carrying amount of equity-accounted investments has changed as follows in the six months to June 2017:

 

 

6 months ended 30 June

2017

£000

Carrying amount

 

At 1 January 2017

182

Share of profit of associate

99

At 30 June 2017

281

 

10. Financial risk management and financial instruments

 

The Group's activities expose it to a variety of financial risks including foreign exchange risk, interest rate risk, credit risk and liquidity risk.

 

The condensed interim financial statements do not include all financial risk management information and disclosures required in the annual financial statements; they should be read in conjunction with the Group's Annual Financial Statements as at 31 December 2016. There have been no changes in the Group's risk management policies since the year end. 

 

Fair value measurement

The following table provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair value is observable.

·     Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities.

·     Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).

·     Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

At 30 June 2017

 Level 1

                     £000

                 Level 2

                    £000

Level 3

£000

Total

£000

Financial assets

 

 

 

 

Foreign exchange derivative

                   -

         495 

-

              495

 

                   -

495 

-

              495

Financial liabilities

 

 

 

 

Interest rate swap

                   -

 356 

-

              356

 

                   -

356 

-

              356

 

At 30 June 2016

Level 1

£000

Level 2

£000

Level 3

£000

Total

£000

Financial liabilities

 

 

 

 

Interest rate swap

-

750

-

750

Foreign exchange derivative

-

581

-

581

 

-

1,331

-

1,331

 

At 31 December 2016

Level 1

£000

Level 2

£000

Level 3

£000

Total

£000

Financial liabilities

 

 

 

 

Interest rate swap

-

525

-

525

Foreign exchange derivative

-

154

-

154

 

-

679

-

679

 

Valuation techniques used to derive Level 2 fair values

Level 2 derivatives comprise foreign exchange derivatives and interest rate swaps. The foreign exchange derivatives have been fair valued using exchange rates that are quoted in an active market. Interest rate swaps are valued using forward interest rates extracted from observable yield curves.

 

Fair values of other financial liabilities and assets

All financial assets and financial liabilities have been recognised at their carrying values which are not materially different to their fair values.

 

 

11. Bank loans and overdrafts

The Group has a £65 million multi-currency facility agreement with Lloyds Bank plc, HSBC Bank plc and Barclays Bank plc and a £5 million committed overdraft facility with Lloyds Bank plc. This remains unchanged from last year. Both facilities are due to expire in May 2019.

 

 

12. Provisions

 

 

Property

£000

Reorganisation

and other

£000

Total

£000

At 1 January 2017

602

3,532

Arising during the year

39

-

39

Released during the year

(20)

(22)

(42)

Utilised

(1,194)

(415)

(1,609)

Transfer

(75)

-

(75)

Foreign exchange movements

(35)

(3)

(38)

Unwind of discount

6

-

6

At 30 June 2017

1,651

162

1,813

Current

380

141

521

Non-current

1,271

21

1,292

 

 

Property provisions

Provisions for property represent amounts set aside in respect of property leases which are onerous and the unavoidable costs of restoring leasehold properties to the condition specified in the lease at the end of the contractual term. The quantification of these provisions has been determined based on external professional advice and is dependent on the Group's ability to exit the leases early or to sublet the properties. In general, property costs are expected to be incurred over a range of one to eight years.

 

Reorganisation and other provisions

This provision relates principally to redundancy provisions.  

 

13. Cash flow analysis

(a) Reconciliation of operating profit/(loss) to net cash inflow/(outflow) from operations

 

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Operating profit/(loss)

10,121

(7,880)

(14,529)

Share of profit from associate

(99)

-

(57)

Amortisation of intangible assets

537

539

1,046

Impairment of intangible assets

-

15,034

30,786

Operating profit before non-cash highlighted items

10,559

7,693

17,246

Depreciation

1,423

1,320

2,737

Share option charge

655

269

234

Loss on disposal of property, plant and equipment

3

48

72

Unrealised (profit)/loss on foreign exchange derivatives

(649)

581

154

Remeasurement of contingent consideration receivable

102

-

-

Profit  on disposal of subsidiaries and investments

-

-

(436)

Operating cash flow before movements in working capital

12,093

9,911

20,007

Increase in work in progress

(2,067)

(1,336)

(1,712)

Increase in debtors

(7,967)

(6,874)

(6,125)

Increase/(decrease) in creditors

4,426

(1,403)

2,339

Decrease in provisions

(1,379)

(1,640)

(1,869)

Net cash inflow/(outflow) from operations

5,106

(1,342)

12,640

Cash flows from highlighted items

1,300

1,399

2,999

Net cash inflow from operations before highlighted items

6,406

57

15,639

 

 (b) Reconciliation of net cash flow to movement in net debt

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Increase in cash and cash equivalents in the period

22,345

671

3,565

Cash inflow from movements in debt

(17,975)

(6,975)

(5,975)

Repayment of capital element of finance leases

1

2

24

Change in net debt resulting from cash flows

4,371

(6,302)

(2,386)

Amortisation and write off of loan fees

(132)

(133)

(264)

New finance lease

-

(7)

(6)

Movement in fair value of derivative financial instruments

818

(1,239)

(587)

Translation differences

(282)

956

2,000

Decrease/(increase) in net debt

4,775

(6,725)

(1,243)

Net debt at beginning of period

(31,614)

(30,371)

(30,371)

Net debt at end of period

(26,839)

(37,096)

(31,614)

 

 (c) Analysis of net debt

 

Unaudited

6 months ended 30 June 2017

£000

Unaudited

6 months ended 30 June 2016

£000

Audited

Year ended

31 December 2016

 £000

Cash and short-term deposits

36,656

10,544

14,978

Bank overdraft

(110)

-

(495)

Bank loans

(63,519)

(46,280)

(45,412)

Derivative financial assets/(liabilities)

139

(1,331)

(679)

Obligations under finance leases

(5)

(29)

(6)

Net debt

(26,839)

(37,096)

(31,614)

14. Related party transactions

The ultimate controlling party of the Group is Huntsworth plc (incorporated in the United Kingdom). The Group has a related party relationship with Directors and executive officers. There were no material related party transactions other than the remuneration of key management personnel of £1.2 million in the six months ended 30 June 2017 (2016: £0.9 million).

 

15. Post balance sheet events

On 1 July 2017 Huntsworth plc acquired all of the issued shares in The Creative Engagement Group Limited for cash consideration of £24.7million.

The financial effects of the above transaction have not been brought into account at 30 June 2017. The operating results and assets and liabilities of the company will be brought into account from 1 July 2017. The fair value calculation of assets and liabilities acquired is on-going.

 

 

 

Independent review report to Huntsworth plc

 

Report on the consolidated interim financial statements

Our conclusion

We have reviewed Huntsworth plc's consolidated interim financial statements (the "interim financial statements") in the half year report of Huntsworth plc for the 6 month period ended 30 June 2017. Based on our review, nothing has come to our attention that causes us to believe that the interim financial statements are not prepared, in all material respects, in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority.

What we have reviewed

The interim financial statements comprise:

1.     the Condensed Consolidated Balance Sheet as at 30 June 2017;

2.     the Condensed Consolidated Income Statement and Condensed Consolidated Statement of Comprehensive Income for the period then ended;

3.     the Condensed Consolidated Cash Flow Statement for the period then ended;

4.     the Condensed Consolidated Statement of Changes in Equity for the period then ended; and

5.     the explanatory notes to the interim financial statements.

The interim financial statements included in the half year report have been prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', as adopted by the European Union and the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority.

As disclosed in note 1 to the interim financial statements, the financial reporting framework that has been applied in the preparation of the full annual financial statements of the Group is applicable law and International Financial Reporting Standards (IFRSs) as adopted by the European Union.

Responsibilities for the interim financial statements and the review

Our responsibilities and those of the directors

The half year report, including the interim financial statements, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half year report in accordance with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority.

Our responsibility is to express a conclusion on the interim financial statements in the half year report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of complying with the Disclosure Guidance and Transparency Rules sourcebook of the United Kingdom's Financial Conduct Authority and for no other purpose.  We do not, in giving this conclusion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

What a review of interim financial statements involves

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures.

A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and, consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

We have read the other information contained in the half year report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the interim financial statements.

PricewaterhouseCoopers LLP

Chartered Accountants

London

 25 July 2017

       

Statement of Directors' Responsibilities

 for the six months ended 30 June 2017       

 

We confirm that to the best of our knowledge this interim report:

 

- has been prepared in accordance with IAS 34 ‘Interim Financial Reporting’;

 

   - includes a fair review of the information required by the Financial Conduct Authority’s Disclosure and Transparency Rules (‘DTR’) 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

 

    - includes a fair review of the information required by DTR 4.2.8R (disclosure of related party transactions and changes therein).

 

By order of the Board

 

 

 

 

 

Paul Taaffe

Chief Executive

       

Appendix 1: non-IFRS measures

 

This report makes reference to various non-IFRS measures, which are defined below. All performance based measures are presented to provide insight into ongoing profit generation, both individually and relative to other companies.

Headline operating profit/profit before tax

Calculated as operating profit/profit before tax excluding highlighted items. Highlighted items in the current year comprise amortisation of intangible assets, acquisition/transaction related costs and the remeasurement of contingent consideration receivable. In prior periods, goodwill impairment, restructuring costs and impairment of software development costs were also included in highlighted items.

Both headline profit and IFRS profit measures are presented in the income statement. An analysis of highlighted items is presented in Note 3.

Margin

Headline operating profit as a percentage of revenue.

Headline basic and diluted EPS

Headline basic EPS is calculated using profit for the period before highlighted items. Headline diluted EPS is the same calculation but takes into account the impact of share options in issue and deferred consideration that could be settled in shares. Details of the underlying inputs to headline and IFRS measures of EPS are included in Note 7.

Net debt

Net debt is the total of current and non-current borrowings and derivative financial instruments, less cash and cash equivalents. The group uses this as a measure of indebtedness. An analysis of net debt is included in Note 13.

Highlighted cash flows

Highlighted cash flows are the cash flows directly attributable to the items presented within highlighted items in the income statement. A reconciliation of the difference between cash flows before highlighted items and IFRS cash flows is included in Note 13.

Effective tax rate

The effective tax rate is the tax expense incurred by the Group on profit before tax and highlighted items, expressed as a percentage. This provides a more comparable basis to analyse our tax rate both individually and relative to other companies.

Like-for-like

Like-for-like revenues are stated at constant exchange rates and are adjusted to exclude disposals/closures. Constant currency results are calculated by translating prior period foreign currency results using the current period exchange rate. This provides insight into the organic growth of the business. A reconciliation of the material adjustments made between like-for-like revenue growth and absolute revenue growth are included in the table below:

6 months ended 30 June 2017

CDR

Grayling

Red

Huntsworth Health

Total Group

£000

£000

£000

£000

£000

IFRS revenue

10,890

21,028

6,938

55,344

94,200

Business closures

-

-

-

-

-

Like-for-like revenue

10,890

21,028

6,938

55,344

94,200

 

6 months ended 30 June 2016

CDR

Grayling

Red

Huntsworth Health

Total Group

£000

£000

£000

£000

£000

IFRS revenue

10,655

27,817

6,598

41,486

86,556

Constant exchange rates

600

2,480

-

4,784

7,864

Business closures

-

(6,045)

-

-

(6,045)

Like-for-like revenue

11,255

24,252

6,598

46,270

88,375

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFSDDTIEFID
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Interim Results for the six months to 30 June 2017 - RNS